Amneal-Impax merger Archives - CDR

Allergan COO to become Amneal CEO

December 20, 2017 by Chain Drug Review Allergan, Amneal Pharmaceuticals, Amneal-Impax merger, Brent Saunders, Chintu Patel, Chirag Patel, Impax Laboratories, Paul Bisaro, Robert Stewart, Wayne Swanton Business, Supplier News

NEW YORK — Merger partners Amneal Pharmaceuticals LLC and Impax Laboratories Inc. have tabbed Robert Stewart, executive vice president and chief operating officer of Allergan plc, to lead the combined company. Plans call for Stewart to join Amneal as president effective Jan. 25. After Amneal and Impax finalize their merger, announced in mid-October, he will

Amneal, Impax agree to merge

October 17, 2017 by Chain Drug Review Amneal Pharmaceuticals, Amneal Pharmaceuticals Inc., Amneal-Impax merger, Chintu Patel, Chirag Patel, Impax Laboratories, Paul Bisaro Business, Leading Headlines, Pharmacy, Supplier News

NEW YORK — Amneal Pharmaceuticals LLC and Impax Laboratories Inc. plan to merge in an all-stock transaction. An Amneal-Impax merger would create the fifth-largest generics supplier by gross revenue in the United States. To be named Amneal Pharmaceuticals Inc., the new entity will also possess a growing, high-margin specialty drug franchise. Financial terms of the deal